KraneShares MSCI All China Health Care Index ETF (KURE)

Overview

The KraneShares MSCI All China Health Care Index ETF (KURE) seeks to track the investment results of the MSCI All China Health Care Index, providing exposure to Chinese companies in the healthcare sector. It primarily invests in publicly listed stocks of companies involved in pharmaceuticals, medical equipment, and healthcare services.

Reputation and Reliability

KraneShares is a well-known issuer specializing in China-focused ETFs, demonstrating a commitment to providing targeted access to the Chinese market. They are considered reliable in the ETF space, known for their expertise and specialized knowledge of Chinese markets.

Management Expertise

KraneShares' management team possesses extensive knowledge and experience in managing China-focused investments. They leverage their understanding of the Chinese market and regulatory environment to effectively manage their ETFs.

Goal

The primary goal of KURE is to provide investment results that closely correspond, before fees and expenses, to the performance of the MSCI All China Health Care Index.

Investment Approach and Strategy

Strategy: KURE employs a passive management strategy, aiming to replicate the performance of its benchmark index. The ETF invests substantially all of its assets in the securities that make up the index.

Composition KURE primarily holds stocks of Chinese companies involved in the healthcare industry, including pharmaceuticals, medical equipment, biotechnology, and healthcare services. The specific composition varies based on the index methodology and market capitalization of constituent companies.

Market Share: KURE has a moderate market share within the China healthcare ETF segment.

Total Net Assets (AUM): 67290000

Key Competitors

• Global X China Healthcare ETF (CHIH)

Competitive Landscape

The China healthcare ETF space is relatively concentrated. KURE has an advantage due to its first-mover advantage and established brand recognition. CHIH offers a similar investment strategy but may have differences in index construction and expense ratios. KURE's and CHIH's advantage is focused on the Chinese healthcare market, however a disadvantage is that the Chinese regulatory environment is very different from the United States and might add to volatility.

Historical Performance: Historical performance data should be sourced from financial data providers. Past performance is not indicative of future results.

Benchmark Comparison: The ETF's performance can be compared to the MSCI All China Health Care Index to assess tracking error.

Expense Ratio: 0.79

Average Trading Volume

KURE's average trading volume indicates moderate liquidity, facilitating relatively easy buying and selling of shares.

Bid-Ask Spread

The bid-ask spread for KURE reflects the cost of trading and provides insight into its market efficiency.

Market Environment Factors

Economic growth in China, healthcare reforms, aging population, and increasing demand for healthcare services drive the performance of KURE. Regulatory changes and government policies also significantly influence the sector.

Growth Trajectory

KURE's growth trajectory depends on the performance of the Chinese healthcare sector, expansion of the index constituents, and investor demand for China-focused healthcare investments. Strategy and holdings typically mirror the underlying index constituents, with occasional rebalancing.

Competitive Edge

KURE's competitive edge lies in its focus on the Chinese healthcare market and its established track record. The ETF offers investors a targeted way to access the growth potential of China's healthcare sector. The ETF benefits from KraneShares' expertise and dedicated focus on China-related investments and benefits from its established reputation and understanding of the Chinese market, providing a valuable resource for investors.

Volatility

KURE's volatility is influenced by the volatility of the Chinese stock market and the healthcare sector. It is advisable to examine historical volatility metrics from trusted sources.

Market Risk

Specific risks include regulatory risks, political risks, currency risks, and economic risks associated with investing in China, as well as sector-specific risks related to healthcare policies and pharmaceutical pricing.

Ideal Investor Profile

KURE is suitable for investors seeking exposure to the Chinese healthcare sector and who have a higher risk tolerance due to the volatility associated with emerging markets. Investors should have a long-term investment horizon and be comfortable with fluctuations in value.

Market Risk

KURE is suitable for long-term investors seeking targeted exposure to China's healthcare market and willing to accept higher volatility and market risk. It is less suitable for risk-averse investors or those seeking stable income.

The KraneShares MSCI All China Health Care Index ETF (KURE) offers investors targeted access to the Chinese healthcare market by tracking the MSCI All China Health Care Index. Its performance is closely linked to the growth and regulatory environment of the Chinese healthcare sector. The ETF provides moderate liquidity, and its suitability is geared towards long-term investors with a higher risk tolerance who understand the complexities of the Chinese market. KraneShares' expertise in managing China-focused ETFs adds to the ETF's appeal for those looking to capitalize on China's growing healthcare industry.

Data Sources:

• KraneShares Official Website
• ETF.com
• Morningstar
• Bloomberg

Disclaimers:

The information provided is for informational purposes only and should not be considered investment advice. Investment decisions should be based on individual risk tolerance and due diligence. Past performance is not indicative of future results.